Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.

Simpson, S H

Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association Jul 2015 - 899-906 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1464-5491

10.1111/dme.12692 doi


Aged
Canada--epidemiology
Cardiovascular Diseases--complications
Combined Modality Therapy--economics
Cost-Benefit Analysis
Diabetes Mellitus, Type 2--complications
Diabetic Angiopathies--economics
Diabetic Cardiomyopathies--economics
Drug Monitoring--economics
Female
Follow-Up Studies
Health Care Costs
Humans
Male
Middle Aged
Patient Acceptance of Health Care
Patient Care Team--economics
Pharmacists--economics
Primary Health Care
Risk Factors